Introduction
Sir Max Rosenheim (Chairman) referred, in his opening remarks, to the new dimension added to preventive medicine and therapeutics by the possibility of presymptomatic diagnosis. This had, of course, long been in use in the form of mass chest X-ray and here it was of proven value, for the early tuberculous lesion responded excellently to treatment. It was, however, now possible to detect conditions for which no treatment was available or for which the value of early treatment remained unproven. We did not know whether the treatment of asymptomatic hypertension, found at routine insurance examination, prolonged life, but attempts to organize efforts to detect such hypertension would certainly lead to widespread anxiety.
When a new and effective method of treating a hitherto uncontrollable condition appeared, we were often found to be ignorant of its natural history so that the effects of treatment were difficult to assess. Presymptomatic diagnosis, whether clinical, radiological or biochemical, was clearly of great importance to both the patient and the clinician but detection for detection's sake was probably unjustified in the absence of sound treatment. It was also costly. There was great need for careful assessment of screening programmes befdre we could decide whether they should be widely accepted and introduced.
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Well-population Screening Screening has been defined as the 'presumptive identification of unrecognized disease or defect by the application of tests, examinations, or other procedures which can be applied rapidly' (Commission on Chronic Illness 1958). The important point in this definition is that screening procedures in themselves are not necessarily diagnostic; the aim of screening is to indicate whether disease is present or the probability that disease is not present, at least among the diseases included in the objectives of the screening programme. Wilson & Jungner (1968) interpret the definition as meaning a 'relatively simple method of case-finding', but there can be overlap between screening and diagnostic procedures since some screening tests, particularly those selected for surveying a limited sector of the population, may also be the most suitable tests to perform for diagnostic purposes.
The criteria to be met by screening tests are listed in Table 1 ; as far as laboratory procedures are concerned, some of these are mutually exclusive. The overriding requirement for a laboratory method is that it should have a high degree of reliability; poor reliability cannot be compensated for by rapidity of operation, and rapid operation is not necessarily accompanied by ease of interpretation. Table 1 Requirements for screening tests (Swartz 1966) (1) Simple to administer (2) Easy to interpret (3) Relatively inexpensive (4) Rapid performance (5) Meet Interest in the use of chemical laboratory examinations as part of well-population screening has developed along two rather different lines:
(1) Simple rapid tests as exemplified by tests on urine (e.g. Clinistix or Phenistix); (2) automatic methods of analysis, particularly using equipment with high throughput capacity, which have allowed tests hitherto only available for diagnostic purposes to be applied to large sectors of the population as screening procedures. Whichever category of test is applied for well-population screening, the sensitivity and specificity of each investigation need to be established.
Sensitivity is defined as the ability of a test to give a positive finding when the person tested truly has the disease under study, and specificity is the ability of the test to give a negative finding when the person tested is free of the disease under study (Thorner & Remein 1961) . Sensitivity and specificity of tests are never absolute, and individuals whose test results fall into the region where the normal overlaps with the abnormal population cannot be classified as normal or diseased-solely on the basis of the one type of screening test. To determine the sensitivity and specificity of a method quantitatively, a true sample of the population under study has to be investigated both by the screening method and by the best diagnostic methods available so as to compare the results of the screening method in detecting the likelihood of the disease being present, and its ability to provide negative results when no disease is present, with the corresponding results of these more searching diagnostic tests.
Screening programmes or disease-detection drives were initially orientated towards specific individual conditions such as diabetes mellitus (Keen 1966 , Malins 1966 , carcinoma of the cervix (Pedersen 1966 , Dunn 1966 or phenylketonuria (Cunningham 1966) . Techniques are now available which make it possible to screen for, but not necessarily diagnose, the presence of many diseases and multiple or multiphasic screening refers to the use of two or more tests when an individual is screened for more than one disease at a single visit (Commission on Chronic
Illness 1957).
Ideally a screening programme should be based on tests which are both sensitive and specific, and the normal population should be clearly demarcated from people with disease. In presymptomatic recognition of disease, which is the area of medicine being explored in wellpopulation screening by means of laboratory tests, clear-cut dividing lines disappear and growing emphasis will be placed on reliable quantitative measurements to characterize people. All-or-none simple stick tests may play an increasing part in screening, and Clinistix have certainly shown themselves valuable in screening for diabetes whereas Phenistix have proved less satisfactory in screening for phenylketonuria. With multiphasic laboratory screening, however, less emphasis will be placed on all-or-none results and more on quantitative results from several tests which can then have their findings subjected to statistical procedures such as multivariate analysis to determine, from the combined results of these several bits of evidence, whether disease probably exists or is probably absent. The ease of stick tests has tended to emphasize wrongly that screening investigations should be rapid.
One of the pioneer studies on repetitive multiphasic health-screening of an ambulant population has been carried out by the Permanente Medical Group in California (Collen 1966) . Subscribers to this health insurance programme present themselves for check-up approximately on an annual basis, and a range of about thirty measurements including eight automated chemical determinations are made during attendance at the clinic. The staff operating the clinic include state-registered nurses and registered laboratory technicians, but many of the measurements are made by aides who are each trained in the performance of a limited range of observations. Data are either punched directly into IBM cards or entered with mark-sensing pencils and subsequently automatically punched in. All data are then processed on an IBM 360 computer and the report sent to the subscriber's doctor for consideration at the physical examination, which is performed subsequent to attendance at the screening clinic.
Another major study in multiphasic screening of a well population has been conducted in Varmland province, Sweden, under the auspices of the Swedish National Board of Health. Although the detailed data published (Jungner 1966a ) are based only on the early years of the survey, further preliminary data confirm the earlier reports (Jungner 1966b ).
The Varmland survey has been a once-for-all investigation offered to all inhabitants over 25 years of age and about 75% have participated. The measurements have been predominantly of a quantitative nature, and mainly chemical examinations; people in whom abnormal findings were detected have been advised to consult their doctors. As explained by Wilson (1963) , this illustrates one of the fundamental problems of screening when used as a public health procedure, since the screening authority incurs responsibility for taking action whenever an abnormal finding is revealed.
With the Varmland study, abnormalities were found in about 12% of the population screened, and the quantitative laboratory examinations were particularly productive in case-finding. In 4% of the population, when the findings were notified to the doctors responsible for the affected individuals, the doctor was already aware of the existence of the abnormality; this is important, as it shows that the screening survey was detecting disease that was already known to exist. In a further 5%, the findings revealed by the survey were reported to the doctors concerned and resulted in a diagnosis being made for the presence of disease not previously suspected; this represents the potentially productive element of the survey, although this statement must be qualified by the observation that there was not, in every case, a recognized method of treatment available for these patients whom the survey had revealed. This leaves 3 % of the Varmland population in whom the screening survey revealed an abnormality, but subsequent examination and investigation of these individuals failed to reveal a diagnosis.
The cost of mounting health-screening surveys of well populations such as the Varmland project is very large, and there are no plans for extending the project as such in Sweden, or even for repeating it in Varmland province. The lessons learned from it will be applied to the planning of different forms of screening evaluation (Jungner, personal communication) . Apart from the cost of such big surveys, the evaluation of abnormalities in asymptomatic individuals can present difficulties, and the problem of the undiagnosed abnormality is one of the most powerful reasons for advocating caution before multiphasic screening programmes are adopted widely as a basic component of medicine in the future. These two reasons are sufficient to account for the changing area of emphasis in the use of laboratory screening procedures. Bryan et al. (1966) reported on the value of hospital admission profiles of chemical investigations and other studies have extended these observations (Young & Drake 1966 , Whitehead 1967 . The following comments are based on experience gained in general practice in Edinburgh, where 1,080 ambulant patients were screened as part of a programme for evaluating the hospital model of the Technicon SMA 12 multichannel analyser (Percy-Robb & Whitby 1967).
Since the survey was conducted on patients, abnormalities could be discussed in relation to symptoms and signs. It revealed several patients with unsuspected hyperglycaemia, or mild uramia, and an unexpectedly large number of patients with serum bilirubin values between 1 1 and 1 6 mg/100 ml; these elevated bilirubin values were sometimes accompanied by clinical or other laboratory evidence (e.g. alkaline phosphatase also performed by the SMA 12) of abnormal liver function. Practically no abnormalities were revealed on the electrolyte channels, and most of the abnormal results for protein and albumin determinations were explicable in terms of pregnancy or the taking of oral contraceptives. Fig 1 summarizes the view that multiphasic screening using chemical laboratory investigations, whether applied to well populations or to ambulant patients attending general practitioners or other predetermined groups, will depend greatly on multiple automated analyses on single specimens, and this raises a general problem affecting multiple analysis, illustrated by the bilirubin findings, where the large number of unexplained abnormal results was found to be attributable to shortcomings in the calibrating serum. For analyses on serum from patients, the only satisfactory calibrating material for multichannel analytical instruments is serum, and the general problem of how to calibrate analytical equipment perforniing multichannel analyses will have to be solved; for instance, by users of the SKt,-7 | under investigation and with the diseases for which screening is being conducted. More work is needed on the evaluation of screening programmes conducted on people who already have symptoms and signs of disease, i.e. on patients, and much more learned about the natural history of diseases and their development before screening programmes on well populations should be greatly expanded. Also, for the application of screening to well populations to be successful, advances in treatment must be made.
